International Journal of Cancer · 2000 · 11 citations · 19 references
MedicineOncologyPharmacologyBreast OncologyCancer PharmacologyEndocrine OncologyHormonal Cancer TherapyHormonal TherapyAntiproliferative AgentsAntiproliferative Drug ActionComplete Response AssessmentEstrogen PharmacologyPartial Response Assessment
The antiproliferative effect of the new antiestrogen EM-800 has been studied during 40 weeks of treatment on human breast carcinoma ZR-75-1 xenografts in ovariectomized nude mice supplemented with estrone (0.5 microg, s.c. daily). At the daily 50 microg (approximately 2.5 mg/kg) oral dose, EM-800 caused a complete inhibition of the 680% stimulatory effect of estrone on the growth of the ZR-75-1 human breast cancer xenografts. Complete response, defined as the complete disappearance of the tumors, was observed in 41% of tumors following treatment with the 50 microg dose of the antiestrogen, while a value of 26% was found in ovariectomized animals. The proportion of tumors showing progression at the end of 40 weeks of treatment decreased from 94% in the estrone-supplemented animals to 62%, 61% and 19% in the animals receiving the 5 microg, 20 microg and 50 microg daily doses of the antiestrogen, respectively. None of the tumors that showed a complete or a partial response progressed at later time intervals. The 50 microg daily dose of EM-800 nearly completely (93%) or completely (28% below the value in ovariectomized animals) reversed the stimulatory effect of estrone on uterine and vaginal weight, respectively. The disappearance of 41% of tumors in the group of animals that received the 50 microg daily dose of EM-800 indicates that the antiestrogen induces cell death or apoptosis in ZR-75-1 human breast cancer cells and that its action is cytotoxic and not only cytostatic.
19
Sarah Landis, Thomas S. Murray, S. Bolden et al. · CA A Cancer Journal for Clinicians · 1999 · 3.1K citations · Full text
Medicine, Biostatistics, Oncology +17
Estrogen Receptors in Human Breast Cancer
T.J. Powles · Journal of Clinical Pathology · 1976 · 614 citations · Full text
Medicine, Cancer Biology, Oncology +14
Contrasting actions of tamoxifen on endometrial and breast tumor growth in the athymic mouse.
Marco M. Gottardis, Simon P. Robinson, P.G. Satyaswaroop et al. · PubMed · 1988 · 423 citations
Medicine, Endocrinology, Oncology +15